Peri-implant inflammation increases the risk of osteonecrosis in mice treated with bisphosphonate
{{output}}
Background: Bisphosphonates (BPs) are effective in managing bone diseases due to their anti-resorptive properties but are linked to medication-related osteonecrosis of the jaw (MRONJ), particularly concerning dental implants. Thi... ...
